BioSpace News Archive

SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it received simultaneous CE Mark certification for its Cranial Module and Percutaneous Spine Module for the 7D FLASH™ Navigation System.

Dynavax Technologies Corporation today announced that it will participate in the following investor conferences. 2021 Cantor Virtual Global Healthcare Conference Dynavax Presentation: Thursday, September 30, 2021, 12:00 p.m. E.T.

Pfizer Inc. (NYSE: PFE) announced today that the first participants have been dosed in a Phase 1 clinical trial to evaluate the safety, tolerability, and immunogenicity of a single dose quadrivalent mRNA vaccine against influenza in healthy adults.

StageZero Life Sciences, Ltd., a healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through lab developed tests and clinical interventions, is pleased to announce that its common shares have been approved for trading on the OTCQB in the United States under the symbol SZLSF.

Innovent Biologics, Inc. and UNION therapeutics A/S today announced that they have entered into a strategic collaboration and license agreement for the development and commercialization of orismilast in China.

ASC Therapeutics announces the appointment of Gary Potter as Senior Vice President, Global Operations.

BioArctic AB’s partner Eisai announced that they have initiated a rolling submission to the U.S. Food and Drug Administration of a Biologics License Application for lecanemab, an investigational anti-amyloid beta protofibril antibody, for the treatment of early Alzheimer’s disease.

Track-etched membranes have well-defined pore structures and pore size distributions. The pore size and the density of track-etched membranes is independently controlled during the production process.

The global surgical robotics systems market is driven by mechanical headways in the medicinal services industry, increment in geriatric populace, and high pervasiveness of development limiting ailments.

Researchers are shifting focus on nonstructural protein 1, also called the SARS-CoV-2 protein, which is found to interact with the intracellular protein production to suppress the translation of mRNA into protein.